United States · 
Who invested in Ajax Therapeutics?
Ajax Therapeutics's investors include Goldman Sachs, RA Capital Management, Point72 Ventures, Vivo Capital and Goldman Sachs Assetmanagement.
United States · Series C startup
Who invested in Ajax Therapeutics
Funding summaryUpdated 26 Oct 2026
$95Mraised across 1 round since 2024, from 1 source
- Latest round
- Series C, $95MMay 2024
- Investors
- 5
The rounds
- May 2024Series C$95M
Source recordedSEC filing: $95M sold, first sale Apr 2024
Founders and team
From the SEC filings it signed: 1 on the team.
- Martin VogelbaumExecutive Officer, Directori
On the board, as filediRamy FaridRoss LevineScott Platshon
Everyone who backed them
Goldman Sachs AssetmanagementVC firm1round
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
This firm lists Ajax Therapeutics as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.
Quick answers about Ajax Therapeutics
How much has Ajax Therapeutics raised?
Ajax Therapeutics has raised $95M across 1 round since 2024.
When did Ajax Therapeutics last raise?
Ajax Therapeutics's most recent round was a Series C of $95M in May 2024.
What was Ajax Therapeutics's biggest round?
Its most recent round, $95M in May 2024, is also its largest on record.
Who backed Ajax Therapeutics first?
Ajax Therapeutics's first round on record, in May 2024, was backed by Goldman Sachs, RA Capital Management and Point72 Ventures and 2 others.
What stage is Ajax Therapeutics at?
Ajax Therapeutics's latest named round is a Series C, in May 2024.
Where is Ajax Therapeutics based?
Ajax Therapeutics is based in the United States.
Companies like Ajax Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.